3.4.21.78	(4-Amidinophenyl)-methanesulfonyl fluoride	-	42783	
3.4.21.78	3,4-dichloroisocoumarin	poor	1040	
3.4.21.78	3,4-dichloroisocoumarin	weak inhibition	1040	
3.4.21.78	3-aminobenzamidine	-	91366	
3.4.21.78	4-aminobenzamidine	-	2072	
3.4.21.78	alpha-2-Macroglobulin	-	7367	
3.4.21.78	Alpha1-proteinase inhibitor	-	3381	
3.4.21.78	alpha2-Macroglobulin	-	1068	
3.4.21.78	antithrombin III	-	2368	
3.4.21.78	Aprotinin	-	405	
3.4.21.78	benzamidine	-	579	
3.4.21.78	Bio-x-IGN(AmPhg)P-(Oph)2	specific and irreversible inhibition both in vitro and in cells	122370	
3.4.21.78	C1 esterase inhibitor	-	6673	
3.4.21.78	C6H4CH2SO2-Gly-Pro(4-amidinophenylglycine)P(OPh)2	-	117896	
3.4.21.78	D-Pro-Phe-Arg-CH2Cl	-	93068	
3.4.21.78	diisopropyl fluorophosphate	-	244	
3.4.21.78	guanidinobenzoate	-	96579	
3.4.21.78	isocoumarin	-	117893	
3.4.21.78	Isocoumarins	mechanism-based isocoumarin inhibitors substituted with basic guanidino or isothiureidopropoxy groups	46472	
3.4.21.78	leupeptin	-	217	
3.4.21.78	additional information	not: inhibitors of either thiol-, metallo- or carboxyl-proteinases	2	
3.4.21.78	additional information	ecotin has no effect	2	
3.4.21.78	additional information	inhibited by the extracellular serpins anti-thrombin III and C1-inhibitor and by the non-serpin inhibitor alpha2-macroglobulin	2	
3.4.21.78	additional information	GzmA-mediated reactive oxygen species production and cell death are impaired in pseudo rho0 cells depleted of mitochondrial DNA. Expression of the K56A-NDUFS3 cleavage site mutant in 293T and K562 cells inhibits GzmA-mediated reactive oxygen species production and cell death	2	
3.4.21.78	additional information	substrate specificity-based screening for potential inhibitors from the intracellular serpin family, no enzyme inhibition by Serpinb6b	2	
3.4.21.78	additional information	substrate specificity-based screening for potential inhibitors from the intracellular serpin family, overview. A lineage-specific increase in enzyme cytotoxic potential has driven cognate inhibitor evolution	2	
3.4.21.78	additional information	histone H4 cleavage is blocked by the GzmA inhibitor nafamostat mesylate and by GzmA knockdown using siRNA. Recombinant histone H4 is treated with trichostatin A, an inhibitor of histone deacetylation, revealing that only untreated histones are digested by GzmA	2	
3.4.21.78	nafamostat mesylate	complete inhibition of histone H4 cleavage	239604	
3.4.21.78	Natural high MW inhibitors	binding to charged surfaces protects the enzyme	99496	
3.4.21.78	p-guanidino-C6H4-COOC6H4-p-CN	-	117895	
3.4.21.78	phenylmethanesulfonyl fluoride	-	827	
3.4.21.78	phenylmethylsulfonyl fluoride	-	257	
3.4.21.78	PhNH-CONH-CiTEtOIC	isocoumarinderivate, best inhibitor	117894	
3.4.21.78	phosphonate	-	3397	
3.4.21.78	Protease nexin-1	-	10947	
3.4.21.78	rotenone	the complex I inhibitor hinders GzmA-mediated reactive oxygen species production and cell death	777	
3.4.21.78	Serpinb6b	potent inhibitor, Serpinb6b employs an exosite to specifically inhibit dimeric but not monomeric murine enzyme. Kinetic analysis and modeling of the mGzmA-Serpinb6b Michaelis complex, overview	201702	
3.4.21.78	Soybean trypsin inhibitor	-	544	
3.4.21.78	valinomycin	pretreatment of K562 cells with 16 nmol valinomycin inhibits GzmA and perforin-induced reactive oxygen species generation	5314